优化直接口服抗凝剂的住院患者的抗凝治疗:一个单中心修改的Delphi研究
Andreas Capiau1,2, Justine De Vleeschauwer2, Tine De Backer3,4
1Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.
British journal of clinical pharmacology
|July 3, 2024
概括
更新的指南简化了住院患者的直接口服抗凝剂 (DOAC) 管理. 新的协议解决了术后和非手术场景,旨在优化抗凝治疗,减少不必要的桥梁与低分子量肝素.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 内部医学 内部医学
背景情况:
- 接受直接口服抗凝剂 (DOAC) 的住院患者面临管理挑战.
- 低分子量肝素的桥梁治疗通常不必要地用于DOACs.
- 目前的临床实践需要更新医院住院期间DOAC管理的指南.
研究的目的:
- 更新当地关于直接口服抗凝剂 (DOAC) 术前管理的指导方针.
- 制定针对非手术性住院患者的抗凝管理指南,这些患者需要暂时停止DOAC治疗.
- 在各种住院病例中提供明确的DOAC管理策略.
主要方法:
- 在一所大学医院进行了两步修改的Delphi研究.
- 组建了两个专家小组:一个用于外科手术期间的DOAC管理,另一个用于非手术患者.
- 专家小组完成了两轮在线调查问卷和一次面对面的会议.
主要成果:
- 一个更新的外科手术指南详细说明了推迟手术后恢复DOAC的原因.
- 对非手术性住院患者的新指南概述了DOAC中断的情景.
- 这两份指南都为确定的情况提供了特定的抗凝治疗策略.
结论:
- 医院住院的外科和非外科患者的DOAC管理指南已经更新和开发.
- 这些指南旨在帮助医疗保健提供者管理DOAC治疗.
- 这些指南旨在支持处方者,并加强药剂师主导的处方审查.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
57
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
57
Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K


